University of California, Las Angeles Medical Center is a clinical research site located in Los Angeles, California, United States 90027.
Crixeo Clinical Trials Trust Score: 92/100 (GOOD). This profile has not yet been claimed by the site owner.
University of California, Las Angeles Medical Center has participated in 1 clinical trials.
Therapeutic areas: Recurrent Glioblastoma Multiforme (GBM), Grade 3 Isocitrate Dehydrogenase (IDH) Wildtype Astrocytoma, Grade 3 or 4 Astrocytoma.
Sponsors: Samus Therapeutics, Inc..
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in California · View every site in Los Angeles
Trust Score: 92/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
University of California, Las Angeles Medical Center has a Crixeo Trust Score of 92/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of California, Las Angeles Medical Center has 1 clinical trials on record. Their work covers Recurrent Glioblastoma Multiforme (GBM), Grade 3 Isocitrate Dehydrogenase (IDH) Wildtype Astrocytoma, Grade 3 or 4 Astrocytoma.
University of California, Las Angeles Medical Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.